|
LncRNA
|
Cell proliferation/viability/growth
|
Cell cycle
|
Invasion
|
Cellular function
|
|---|
|
Migration
|
Apoptosis
|
Differentiation
|
Autophagy
|
CSC properties
|
|---|
|
LOC100507661
|
√
| |
√
|
√
| | | | |
|
GAS5
|
√
|
√
| | | | | | |
|
H19
|
√
| |
√
|
√
|
√
| | | |
|
UCA1
|
√
| |
√
|
√
| | | | |
|
HCP5
|
√
| | | |
√
| | | |
|
KLHL14-AS
|
√
| | | |
√
|
√
| | |
|
Linc00210
|
√
| |
√
| | | | | |
|
TNRC6C-AS1
|
√
| |
√
|
√
| | | | |
|
AK139328
|
√
|
√
|
√
| | | | | |
|
LINC00312
|
√
| |
√
|
√
| | | | |
|
XIST
|
√
| | | | | | | |
|
SNHG7
|
√
|
√
| | | | | | |
|
SNHG15
|
√
| |
√
|
√
| | | | |
|
ZFAS1
|
√
|
√
| | | | | | |
|
CASC2
|
√
|
√
| | | | | | |
|
ROR
| | | | | | | |
√
|
|
PVT1
|
√
|
√
| | | | | |
√
|
|
HOTAIR
| | | | | | | |
√
|
|
MALAT1
|
√
| |
√
|
√
|
√
| |
√
|
√
|
|
BANCR
|
√
|
√
| | | | | |
√
|
|
FOXD2-AS1
| | | | | | | |
√
|
|
PTCSC3
|
√
|
√
| | |
√
| | |
√
|
|
MANCR
|
√
|
√
| | |
√
| | |
√
|
|
PAR5
|
√
| | | | | | |
√
|
|
TUG1
|
√
| |
√
|
√
| | | |
√
|
- lncRNAs such as MIR22HG, HOTAIRM1, and PCA3 are involved in the development, progression, and prognosis of ATC, their function in different cellular processes have not yet been determined
- BANCR, BRAF-activated non-protein coding RNA; CASC2, cancer susceptibility candidate 2; CSC, cancer stem cell; FOXD2-AS1, FOXD2 adjacent opposite strand RNA 1; GAS5, growth arrest special 5; HCP5, HLA complex P5; HOTAIR, HOX transcript antisense RNA; Klhl14, kelch like family member 14; Linc00210, long intergenic non-protein coding RNA 210; LINC00312, long intergenic non-protein coding RNA 312; LncRNA, long noncoding RNA, MALAT1: metastasis-associated lung adenocarcinoma transcript 1; MANCR, mitotically associated long non coding RNA; PAR5, Prader Wili/Angelman region RNA 5; PTCSC3, papillary thyroid carcinoma susceptibility candidate 3; PVT1, plasmacytoma variant translocation 1; ROR, regulator of reprogramming; SNHG15, small nucleolar RNA host gene 15; SNHG7, small nucleolar RNA host gene 7; TNRC6C-AS1, TNRC6C antisense RNA 1; TUG1, taurine up-regulated gene 1; UCA1, urothelial carcinoma-associated 1; XIST, X inactive specific transcript; ZFAS1, ZNFX1 antisense RNA 1
